X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs PFIZER - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. PFIZER WOCKHARDT LTD./
PFIZER
 
P/E (TTM) x -11.2 32.9 - View Chart
P/BV x 2.2 4.9 45.5% View Chart
Dividend Yield % 1.5 0.8 191.5%  

Financials

 WOCKHARDT LTD.   PFIZER
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-17
PFIZER
Mar-17
WOCKHARDT LTD./
PFIZER
5-Yr Chart
Click to enlarge
High Rs1,1292,055 54.9%   
Low Rs6271,651 38.0%   
Sales per share (Unadj.) Rs363.1429.8 84.5%  
Earnings per share (Unadj.) Rs-20.473.6 -27.8%  
Cash flow per share (Unadj.) Rs-7.087.4 -8.0%  
Dividends per share (Unadj.) Rs10.0020.00 50.0%  
Dividend yield (eoy) %1.11.1 105.5%  
Book value per share (Unadj.) Rs301.8528.7 57.1%  
Shares outstanding (eoy) m110.5545.75 241.6%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.44.3 56.1%   
Avg P/E ratio x-42.925.2 -170.6%  
P/CF ratio (eoy) x-125.921.2 -593.5%  
Price / Book Value ratio x2.93.5 83.0%  
Dividend payout %-48.927.2 -180.0%   
Avg Mkt Cap Rs m97,06384,777 114.5%   
No. of employees `0006.82.8 238.4%   
Total wages/salary Rs m9,6653,039 318.0%   
Avg. sales/employee Rs Th5,931.86,925.9 85.6%   
Avg. wages/employee Rs Th1,428.11,070.4 133.4%   
Avg. net profit/employee Rs Th-334.01,186.3 -28.2%   
INCOME DATA
Net Sales Rs m40,14619,663 204.2%  
Other income Rs m1,1431,012 112.9%   
Total revenues Rs m41,28920,674 199.7%   
Gross profit Rs m1283,491 3.7%  
Depreciation Rs m1,489629 236.7%   
Interest Rs m2,25310 23,465.6%   
Profit before tax Rs m-2,4723,864 -64.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m01,304 0.0%   
Tax Rs m-2111,801 -11.7%   
Profit after tax Rs m-2,2603,368 -67.1%  
Gross profit margin %0.317.8 1.8%  
Effective tax rate %8.546.6 18.3%   
Net profit margin %-5.617.1 -32.9%  
BALANCE SHEET DATA
Current assets Rs m46,16020,789 222.0%   
Current liabilities Rs m19,2587,870 244.7%   
Net working cap to sales %67.065.7 102.0%  
Current ratio x2.42.6 90.7%  
Inventory Days Days10160 168.6%  
Debtors Days Days9422 419.5%  
Net fixed assets Rs m40,1659,175 437.7%   
Share capital Rs m553458 120.8%   
"Free" reserves Rs m32,81423,731 138.3%   
Net worth Rs m33,36724,189 137.9%   
Long term debt Rs m31,90325 127,610.8%   
Total assets Rs m89,68732,706 274.2%  
Interest coverage x-0.1403.5 -0.0%   
Debt to equity ratio x1.00 92,508.9%  
Sales to assets ratio x0.40.6 74.5%   
Return on assets %010.3 -0.1%  
Return on equity %-6.813.9 -48.7%  
Return on capital %-0.321.4 -1.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,12163 14,500.5%   
Fx outflow Rs m2,1334,067 52.5%   
Net fx Rs m6,988-4,004 -174.5%   
CASH FLOW
From Operations Rs m-2,6953,288 -82.0%  
From Investments Rs m-6,863-2,496 274.9%  
From Financial Activity Rs m12,545-826 -1,518.9%  
Net Cashflow Rs m3,010-35 -8,700.3%  

Share Holding

Indian Promoters % 74.5 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 2.3 7.5 30.7%  
FIIs % 7.7 4.9 157.1%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 23.7 65.0%  
Shareholders   67,757 85,207 79.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   ORCHID PHARMA LTD  CIPLA  ASTRAZENECA PHARMA  VENUS REMEDIES  STERLING BIOTECH  

Compare WOCKHARDT LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Jun 22, 2018 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. - ALKEM LABORATORIES COMPARISON

COMPARE WOCKHARDT LTD. WITH

MARKET STATS